Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.11.2023 | Case report

Budesonide/Montelukast/Salbutamol

Worsening of tachycardia, shortness of breath and chest discomfort

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Umscheid JD, et al. Thyroid Hormone Resistance Syndrome Presenting as Exercise Induced Asthma. Journal of the Endocrine Society 5 (Suppl. 1): A707-A708, May 2021. Available from: URL: https://dx.doi.org/10.1210/jendso/bvab048.1441 [abstract] Umscheid JD, et al. Thyroid Hormone Resistance Syndrome Presenting as Exercise Induced Asthma. Journal of the Endocrine Society 5 (Suppl. 1): A707-A708, May 2021. Available from: URL: https://dx.doi.org/10.1210/jendso/bvab048.1441 [abstract]
Metadaten
Titel
Budesonide/Montelukast/Salbutamol
Worsening of tachycardia, shortness of breath and chest discomfort
Publikationsdatum
01.11.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-50353-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Pembrolizumab

Case report

Antineoplastics

Case report

Alpelisib